Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of MATHYS Scale in Bipolar Patients Treated With Olanzapine
NCT00259272Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2005
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olanzapine in bipolar disorder (BD), sponsored by Eli Lilly and Company. Started Nov 2005; status: completed.
02
Drugs
olanzapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00259272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259272.